K Shimokata Selected Research

K Shimokata Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 12/2004 - 04/2000
6	Neoplasms (Cancer) 07/2001 - 04/2000
4	Asthma (Bronchial Asthma) 02/2009 - 04/2007
3	Inflammation (Inflammations) 02/2009 - 06/2003
2	Fibrosis (Cirrhosis) 06/2003 - 05/2000
2	Carcinogenesis 07/2001 - 05/2001
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2008
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2007
1	Eosinophilia 04/2007
1	Hyperplasia 04/2007
1	Disease Progression 06/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2006
1	Brain Neoplasms (Brain Tumor) 12/2004
1	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 08/2001
1	Malignant Mesothelioma 07/2001
1	Adenocarcinoma 07/2001
1	Mesothelioma 07/2001
1	Adenoma (Adenomas) 05/2001
1	Diffuse panbronchiolitis 03/2001
1	Uremia 02/2001
1	Leukopenia 12/2000
1	Diarrhea 12/2000
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2000
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2000
1	Sclerosis 05/2000
1	Proteinuria 04/2000
1	Infections 04/2000
1	Hypersensitivity (Allergy) 04/2000
1	Glomerulonephritis 04/2000
1	Azotemia 04/2000

Drug/Important Bio-Agent (IBA)

3	Codon (Codons)IBA 07/2001 - 05/2000
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2001 - 12/2000
2	Proteins (Proteins, Gene)FDA Link 07/2001 - 05/2001
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2009
1	ProstaglandinsIBA 02/2009
1	Oxidants (Oxidizing Agents)IBA 02/2009
1	IsoprostanesIBA 02/2009
1	Tryptases (Tryptase)IBA 01/2008
1	PAR-2 ReceptorIBA 01/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2008
1	Adenosine Triphosphate (ATP)IBA 06/2007
1	Methacholine Chloride (Methacholine)FDA Link 04/2007
1	Interleukin-5 (Interleukin 5)IBA 04/2007
1	CytokinesIBA 04/2007
1	AllergensIBA 04/2007
1	fasudil (AT 877)IBA 04/2007
1	ChemokinesIBA 04/2007
1	Interleukin-13IBA 04/2007
1	rho-Associated KinasesIBA 04/2007
1	Gefitinib (Iressa)FDA Link 06/2006
1	gadoteridol (Prohance)FDA Link 12/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2003
1	Carboplatin (JM8)FDA LinkGeneric 12/2001
1	beta CateninIBA 07/2001
1	Interferon-gamma (Interferon, gamma)IBA 06/2001
1	CD40 Ligand (CD40L)IBA 06/2001
1	Messenger RNA (mRNA)IBA 05/2001
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2001
1	Urethane (Ethyl Carbamate)IBA 05/2001
1	Erythromycin (Erycette)FDA LinkGeneric 03/2001
1	Glutathione (Reduced Glutathione)IBA 02/2001
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 02/2001
1	glutathionyl hemoglobinIBA 02/2001
1	DisulfidesIBA 02/2001
1	CreatinineIBA 05/2000
1	AST 120IBA 05/2000
1	IndicanIBA 05/2000
1	Insulin (Novolin)FDA Link 05/2000
1	NucleotidesIBA 05/2000
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2000
1	Thymidine KinaseIBA 04/2000
1	Fc Receptors (Fc Receptor)IBA 04/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2000
1	Immunoglobulin G (IgG)IBA 04/2000
1	antiglomerular basement membrane antibodyIBA 04/2000
1	GuanosineIBA 04/2000
1	Etoposide (VP 16)FDA LinkGeneric 04/2000
1	Pharmaceutical PreparationsIBA 04/2000
1	DNA (Deoxyribonucleic Acid)IBA 04/2000
1	Complement System Proteins (Complement)IBA 04/2000
1	Cisplatin (Platino)FDA LinkGeneric 04/2000
1	Docetaxel (Taxotere)FDA Link 04/2000
1	9- ((cis- 1,2- bis(hydroxymethyl)cycloprop- 1- yl)methyl)guanineIBA 04/2000
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2000

Therapy/Procedure

1	Oral Administration 04/2007
1	Therapeutics 06/2006
1	Catheter Ablation 08/2001
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2001
1	Renal Dialysis (Hemodialysis) 02/2001
1	Intravenous Injections 04/2000